NCT00004060View on ClinicalTrials.gov

Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1999

Primary Completion Date

September 30, 2000

Study Completion Date

September 30, 2000

Conditions
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Interventions
DRUG

exatecan mesylate

Trial Locations (1)

77030

University of Texas - MD Anderson Cancer Center, Houston

Sponsors

Lead Sponsor

Daiichi Sankyo
All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY